Milton H. Werner
2023
In 2023, Milton H. Werner earned a total compensation of $811.4K as President and Chief Executive Officer at Inhibikase Therapeutics, a 9% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $170,850 |
|---|---|
| Option Awards | $113,472 |
| Salary | $510,000 |
| Other | $17,107 |
| Total | $811,429 |
Werner received $510K in salary, accounting for 63% of the total pay in 2023.
Werner also received $170.9K in non-equity incentive plan, $113.5K in option awards and $17.1K in other compensation.
Rankings
In 2023, Milton H. Werner's compensation ranked 1,417th out of 2,891 executives tracked by ExecPay. In other words, Werner earned more than 51.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,417 out of 2,891 | 51st |
Division Manufacturing | 845 out of 1,584 | 47th |
Major group Chemicals And Allied Products | 551 out of 893 | 38th |
Industry group Drugs | 537 out of 856 | 37th |
Industry Biological Products, Except Diagnostic Substances | 150 out of 211 | 29th |
Source: SEC filing on November 18, 2024.
Werner's colleagues
We found one more compensation record of an executive who worked with Milton H. Werner at Inhibikase Therapeutics in 2023.
2023
Joseph Frattaroli
Inhibikase Therapeutics